Drugdiscovery >> Clinical Trials >> News
7756
Views
AstraZeneca’s olaparib to enter Phase 3 clinical program for ovarian cancer - drugdiscovery.com
AstraZeneca’s olaparib to enter Phase 3 clinical program for ovarian cancer - drugdiscovery.com


AstraZeneca has initiated the enrollment of patients for a Phase III (SOLO) clinical program of its drug olaparib. The drug will be tested as a maintenance monotherapy in patients with BRCA mutated ovarian cancer, who are in complete or partial response following platinum-based chemotherapy.
Read More >>


Tags: ovarian cancer, clinical trial, olaparib, AstraZeneca, SOLO, BRCA mutation, PARP inhibitor - September 7, 2013
Related Articles
3361
Views
New clinical trial in ovarian cancer New clinical trial in ovarian cancer
Adaptimmune has opened a Phase I/IIa clinical trial at Roswell Park Cancer Institute (RPCI) in Buffalo, N.Y., and City of Hope (COH) in Duarte, Calif. The patients will be treated with their own T ce Read More >>

Tags: ovarian cancer, T cells, cancer immunotherapy, TCR enhancement technology, CT antigens

4483
Views
Ovarian cancer drug demcizumab enters Phase 2 Ovarian cancer drug demcizumab enters Phase 2
OncoMed Pharmaceuticals’ stem cell product candidate, demcizumab (OMP-21M18) has entered Phase 1b/2 clinical trial and will be tested in combination with paclitaxel in patients with platinum-resista Read More >>

Tags: OncoMed, oncomed, demcizumab, ovarian cancer, fallopian tube cancer, primary peritoneal cancer

3383
Views
Cediranib beneficial for women with recurrent ovarian cancer Cediranib beneficial for women with recurrent ovarian cancer
The results of a Phase 3 trial show that cediranib, a tyrosine kinase inhibitor of cell signalling process involved in formation of tumor blood vessels, improves survival in women with ovarian cancer Read More >>

Tags: cediranib, tyrosine kinase inhibitor , clinical trial, ovarian cancer

5265
Views
New Alzheimer drug enters Phase 3 program New Alzheimer drug enters Phase 3 program
Lundbeck/ Otsuka Pharmaceutical’s investigational compound, Lu AE58054, is entering the first out of four Phase 3 clinical trials for the treatment of Alzheimer's disease. Lu AE58054 has a different Read More >>

Tags: Lundbeck, Otsuka, Alzheimer disease, investigational drug, new drug, treatment, clinical trial

6955
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

3048
Views
Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer
Merck Serono’s Erbitux (cetuximab) plus FOLFIRI, compared to bevacizumab plus FOLFIRI, has shown a clinically relevant improvement (7.5 month increase in median overall survival) as first-line tr Read More >>

Tags: Erbitux, cetuximab, clinical trail, metastatic, colorectal cancer, Merck, cancer therapy

6271
Views
Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial
The experimental vaccine consists of a disk-shaped, biodegradable sponge which contains growth factors and components of each patient's tumors aiming to recruit and reprogram a patient’s own immune Read More >>

Tags: melanoma, cancer, clinical trial, skin, implant, implantable, vaccine

15910
Views
Novel brain cancer drug proceeds to the Phase II clinical trial Novel brain cancer drug proceeds to the Phase II clinical trial
The major obstacle for the treatment of malignant brain diseases is the protective blood-brain barrier (BBB), which restricts drug delivery into the central nervous system. To circumvent this issue, a Read More >>

Tags: blood-brain barrier, brain tumor, brain cancer, drug delivery, doxorubicin, G-Technology, liposome

20248
Views
Lilly’s experimental lung cancer drug successful in phase III clinical trial Lilly’s experimental lung cancer drug successful in phase III clinical trial
Eli Lilly & Co. announced in a press release that necitumumab (IMC-11F8), in combination with gemcitabine and cisplatin, as first-line treatment for stage IV squamous cell non-small cell lung cancer Read More >>

Tags: Eli Lilly, necitumumab, advanced lung cancer, new drug,experimental drug, stage IV, squamous cell non-small cell lung cancer

2805
Views
Interferon-free hepatitis coctail of AbbVie enters Phase III Interferon-free hepatitis coctail of AbbVie enters Phase III
The new drug of AbbVie has entered clinical trial phase II. It cures hepatitis C, and provides a ribavirin-free, all-oral treatment without interferon. Read More >>

Tags: interferon, hepatitis C, clinical trial, Phase III

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013